Oncospace
510(k) K222803
Oncospace is a Class II device made by Oncospace, Inc., cleared under FDA 510(k) K222803 on 2 Feb 2023, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK222803 | Date2 Feb 2023 | StatusActive |
Official records
- FDA 510(k) database K222803
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MUJ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.5050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).
- ONCENTRA MANUAL LOW DOSE RATE TREATMENT PLANNING by Nucletron Corp.
- ONCENTRA BRACHY by Nucletron B.V.
- Leksell GammaPlan 1567714 by Elekta Solutions AB
- MODIFICATION TO PROWESS PRO-SIM by Ssgi Prowess Systems
- TRIMED PLAN, VERSION 2.2 by Trimed Systems, Inc.
- RENDER-PLAN 3-D by Precision Therapy Intl., Inc.
- Panther StereoSeed by Prowess, Inc.
- ACCUSOFT, ACCUSOFT XL by Direx Systems Corp.
- OCENTRA MASTERPLAN 3.1 (OCENTRA BRACHY) by Nucletron Corp.
- eXaSkin Plus by Anatomical Geometry S.L.